Holen Sie sich die Stockscreener-App
157.39
2.64%
-4.27
Schlusskurs vom Vortag:
$161.66
Offen:
$161.26
24-Stunden-Volumen:
646.68K
Relative Volume:
0.71
Marktkapitalisierung:
$8.86B
Einnahmen:
$633.51M
Nettoeinkommen (Verlust:
$-8.10M
KGV:
-507.71
EPS:
-0.31
Netto-Cashflow:
$131.26M
1W Leistung:
-4.60%
1M Leistung:
-0.39%
6M Leistung:
+19.87%
1J Leistung:
+0.90%
1-Tages-Spanne:
$156.31
$162.06
1-Wochen-Bereich:
$156.31
$165.02
52-Wochen-Spanne:
$102.97
$182.52
Repligen Corp Stock (RGEN) Company Profile
Firmenname
Repligen Corp
Sektor
Telefon
(781) 449-9560
Adresse
41 SEYON STREET, WALTHAM, MA
Vergleichen Sie RGEN mit anderen Aktien
| Aktien | Preis | Marktkapitalisierung | Umsatz | Nettogewinn | Free Cashflow | ENV |
|---|---|---|---|---|---|---|
RGEN
Repligen Corp
|
157.39 | 9.10B | 633.51M | -8.10M | 131.26M | -0.31 |
|
ISRG
Intuitive Surgical Inc
|
542.32 | 194.04B | 9.61B | 2.77B | 2.27B | 7.555 |
|
BDX
Becton Dickinson Co
|
200.89 | 57.21B | 21.84B | 1.68B | 2.67B | 5.8293 |
|
ALC
Alcon Inc
|
78.80 | 38.69B | 10.19B | 1.05B | 1.38B | 2.1044 |
|
RMD
Resmed Inc
|
252.27 | 36.84B | 5.26B | 1.44B | 1.76B | 9.7713 |
|
WST
West Pharmaceutical Services Inc
|
267.56 | 19.61B | 2.96B | 487.70M | 344.00M | 6.6758 |
Repligen Corp Stock (RGEN) Upgrades & Downgrades
| Datum | Aktion | Analytiker | Ratingänderung |
|---|---|---|---|
| 2025-10-01 | Eingeleitet | HSBC Securities | Buy |
| 2025-09-22 | Hochstufung | Evercore ISI | In-line → Outperform |
| 2025-07-22 | Fortgesetzt | Stephens | Overweight |
| 2025-06-24 | Eingeleitet | Barclays | Overweight |
| 2025-04-29 | Hochstufung | Wolfe Research | Peer Perform → Outperform |
| 2025-03-18 | Eingeleitet | Evercore ISI | In-line |
| 2025-02-10 | Eingeleitet | TD Cowen | Buy |
| 2024-12-17 | Eingeleitet | Canaccord Genuity | Hold |
| 2024-11-14 | Eingeleitet | Wolfe Research | Peer Perform |
| 2024-08-28 | Eingeleitet | Wells Fargo | Overweight |
| 2024-06-26 | Hochstufung | Deutsche Bank | Hold → Buy |
| 2024-06-18 | Eingeleitet | Guggenheim | Neutral |
| 2023-12-04 | Herabstufung | The Benchmark Company | Buy → Hold |
| 2023-07-20 | Eingeleitet | Wells Fargo | Overweight |
| 2023-07-05 | Fortgesetzt | JP Morgan | Overweight |
| 2023-03-28 | Eingeleitet | The Benchmark Company | Buy |
| 2022-12-14 | Eingeleitet | Deutsche Bank | Hold |
| 2022-12-07 | Eingeleitet | RBC Capital Mkts | Sector Perform |
| 2022-07-20 | Eingeleitet | UBS | Buy |
| 2021-10-14 | Eingeleitet | Exane BNP Paribas | Outperform |
| 2020-11-10 | Eingeleitet | KeyBanc Capital Markets | Overweight |
| 2020-08-24 | Bestätigt | H.C. Wainwright | Buy |
| 2020-06-30 | Bestätigt | H.C. Wainwright | Buy |
| 2020-05-07 | Bestätigt | H.C. Wainwright | Buy |
| 2020-03-23 | Bestätigt | H.C. Wainwright | Buy |
| 2019-11-15 | Eingeleitet | Stifel | Buy |
| 2019-11-01 | Hochstufung | First Analysis Sec | Outperform → Strong Buy |
| 2019-10-15 | Eingeleitet | SVB Leerink | Outperform |
| 2019-08-28 | Bestätigt | First Analysis Sec | Outperform |
| 2019-08-23 | Fortgesetzt | Stephens | Overweight |
| 2019-07-22 | Hochstufung | H.C. Wainwright | Neutral → Buy |
| 2018-12-17 | Hochstufung | CL King | Neutral → Buy |
| 2018-11-12 | Herabstufung | CL King | Buy → Neutral |
| 2018-09-26 | Eingeleitet | H.C. Wainwright | Neutral |
| 2017-12-08 | Eingeleitet | Citigroup | Buy |
| 2017-12-05 | Eingeleitet | JP Morgan | Overweight |
| 2017-11-13 | Eingeleitet | CL King | Buy |
| 2017-10-02 | Hochstufung | First Analysis Sec | Equal-Weight → Overweight |
| 2017-07-21 | Eingeleitet | William Blair | Outperform |
| 2017-02-13 | Hochstufung | Piper Jaffray | Neutral → Overweight |
Alle ansehen
Repligen Corp Aktie (RGEN) Neueste Nachrichten
Repligen Corporation $RGEN Shares Purchased by First Trust Advisors LP - MarketBeat
What's Driving the Market Sentiment Around Repligen Corp? - Benzinga
The five-year earnings decline is not helping Repligen's (NASDAQ:RGEN share price, as stock falls another 3.3% in past week - Yahoo Finance
London & Capital Asset Management Ltd Lowers Stock Holdings in Repligen Corporation $RGEN - MarketBeat
Norges Bank Buys New Holdings in Repligen Corporation $RGEN - MarketBeat
Nothing is Better Than Repligen Corp (RGEN) stock at the moment - setenews.com
Does Repligen Corporation (RGN) stock trade below intrinsic value2025 Big Picture & Capital Efficiency Focused Ideas - Newser
Brown Capital Management LLC Has $125.04 Million Position in Repligen Corporation $RGEN - MarketBeat
Why Repligen Corporation stock is rated strong buyRecession Risk & Fast Exit/Entry Strategy Plans - Newser
Schroder Investment Management Group Makes New $25.67 Million Investment in Repligen Corporation $RGEN - MarketBeat
Edgestream Partners L.P. Makes New $3.48 Million Investment in Repligen Corporation $RGEN - Defense World
Repligen Corporation (NASDAQ:RGEN) Given Consensus Rating of “Moderate Buy” by Brokerages - Defense World
Repligen Corporation (NASDAQ:RGEN) Given Consensus Rating of "Moderate Buy" by Brokerages - MarketBeat
Loomis Sayles & Co. L P Acquires New Holdings in Repligen Corporation $RGEN - MarketBeat
Is Repligen Corporation stock attractive for hedge fundsPortfolio Value Report & Fast Moving Stock Trade Plans - Newser
Will Repligen Corporation stock outperform Nasdaq indexJuly 2025 Breakouts & Free Verified High Yield Trade Plans - Newser
How Repligen Corporation (RGN) stock reacts to new regulationsJuly 2025 Technicals & Real-Time Volume Triggers - Newser
Advisors Asset Management Inc. Cuts Holdings in Repligen Corporation $RGEN - Defense World
Rhumbline Advisers Lowers Holdings in Repligen Corporation $RGEN - MarketBeat
Coldstream Capital Management Inc. Sells 321 Shares of Repligen Corporation $RGEN - Defense World
American Century Companies Inc. Sells 2,253 Shares of Repligen Corporation $RGEN - MarketBeat
Repligen Corporation $RGEN Stock Holdings Increased by XTX Topco Ltd - MarketBeat
Aug Chart Watch: Why Repligen Corporation stock is in analyst buy zoneJuly 2025 Opening Moves & Stepwise Trade Signal Guides - moha.gov.vn
AI Stocks: How Repligen Corporation stock reacts to oil prices2025 Geopolitical Influence & Weekly High Return Stock Opportunities - BỘ NỘI VỤ
Insider Sell: Olivier Loeillot Sells 7,041 Shares of Repligen Co - GuruFocus
287,686 Shares in Repligen Corporation $RGEN Bought by Blue Whale Capital LLP - Defense World
Repligen (NASDAQ: RGEN) to Join Evercore Healthcare Conference Webcast Dec. 3 - Stock Titan
Ameritas Investment Partners Inc. Has $2 Million Stake in Repligen Corporation $RGEN - Defense World
Intech Investment Management LLC Buys New Stake in Repligen Corporation $RGEN - MarketBeat
Segall Bryant & Hamill LLC Has $18.48 Million Stock Holdings in Repligen Corporation $RGEN - MarketBeat
Leerink Partnrs Brokers Lift Earnings Estimates for Repligen - Defense World
Why Repligen (RGEN) Stock Is Trading Up Today - Finviz
P/E Ratio Insights for Repligen - Benzinga
Its Stock Has Paid Off Big Time For Repligen Corp - Setenews
Repligen Corporation (RGEN) Stock forecasts - Yahoo Finance UK
RGEN (Repligen) Book Value per Share : $37.01 (As of Sep. 2025) - GuruFocus
Repligen Corporation (RGEN) Stock Price | Live Quotes & Charts | NASDAQ - StocksToTrade
Repligen Chief Operating Officer Sold $331K In Company Stock - Benzinga
Can Repligen Corporation (RGN) stock sustain margin levelsWeekly Volume Report & Target Return Focused Picks - newser.com
How strong is Repligen Corporation stock balance sheetBear Alert & Risk Managed Investment Strategies - newser.com
Using Python tools to backtest Repligen Corporation strategies2025 Sector Review & Short-Term High Return Strategies - newser.com
Insider Sell: James Bylund Sells Shares of Repligen Corp (RGEN) - GuruFocus
REPLIGEN COO James Bylund Sells 2,191 Shares - TradingView
Real time breakdown of Repligen Corporation stock performanceJuly 2025 Opening Moves & Expert Curated Trade Setups - newser.com
Why Repligen Corporation (RGN) stock is upgraded to buyEarnings Overview Summary & Consistent Return Strategy Ideas - newser.com
Is Repligen Corporation (RGN) stock supported by strong fundamentals2025 Short Interest & Verified Short-Term Trading Plans - newser.com
Repligen at Wolfe Research Healthcare Conference: Strategic Growth Insights - Investing.com
Repligen at Jefferies London: Strategic Growth Amid Headwinds - Investing.com
Insider Selling: Repligen (NASDAQ:RGEN) Director Sells $3,092,200.00 in Stock - Defense World
Smart tools for monitoring Repligen Corporation’s price actionWatch List & Safe Entry Point Identification - newser.com
Custom strategy builders for tracking Repligen CorporationDividend Hike & Free Accurate Trade Setup Notifications - newser.com
Finanzdaten der Repligen Corp-Aktie (RGEN)
Umsatz
Nettogewinn
Free Cashflow
ENV
1.32%
0.04%
In Yahoo öffnen
|
In Google öffnen
|
In Finviz öffnen
|
In MarketWatch öffnen
|
Öffnen Sie in EDGAR
|
Offen in Reuters
Kapitalisierung:
|
Volumen (24h):